RecruitingNot ApplicableNCT04697823

Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate.

Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate: a Prospective Randomized Trial


Sponsor

KU Leuven

Enrollment

400 participants

Start Date

Jan 1, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Assessing whether the use of hyaluronan-enriched transfer medium can increase the cumulative ongoing pregnancy rate


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Inclusion Criteria7

  • Patients with own oocytes/embryos;
  • Patients with female age at 1st OR in the study \<40 year;
  • Patients planned for a 2nd oocyte retrieval, with no clinical ongoing pregnancy after the previous oocyte retrieval
  • Patients planned for a 3rd oocyte retrieval with no clinical ongoing pregnancy after previous oocyte retrievals
  • Patients with female age at 1st OR in the study \<40 year;
  • Patients with BMI ≤32;
  • Patients with written informed consent;

Exclusion Criteria1

  • \-

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERuse of hyaluronan-enriched transfer medium

In the study group, an embryo transfer will be performed in hyaluronan-enriched transfer medium


Locations(1)

Leuven University Fertility Center

Leuven, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04697823


Related Trials